>>> Greeks apologise with huge horse (just for fun)

http://www.thedailymash.co.uk/news/international/greeks-apologise-with-huge-horse-2012051527146

Greeks apologise with huge horse
15-05-12


THE nation of Greece said sorry to the European Union with a present of an enormous wooden horse.

Left outside the European Central Bank in the dead of night, the horse has now been moved into the ECB’s central lobby where it is proudly on display.

A gift tag attached to the horse, which is surprisingly light for its size and has small holes along the length of its body, suggested that it should be placed in the bank’s vaults overnight to avoid it being targeted by thieves.

Mario Draghi, President of the ECB, said: “How nice of the Greeks to acknowledge the trouble we’ve been put to on their behalf with this wonderful horse, handmade and so large it could hold a dozen double-decker buses.

“The card with it, which had a teddy bear dressed as a hobo on the front, explained that Greece made us this because they don’t have enough money for a present, which brought a tear to my eye.

“However, unless they can somehow find billions overnight then austerity measures must continue.”

Oddly, Greek representatives in Brussels have hinted that they may soon be in a position to settle their debts and have puzzled the French and German banks that hold their loans by asking if there is any discount for cash.

The government of Spain has reacted angrily to the gift, accusing the Greeks of trying to bribe the ECB and redoubling their own efforts to weave a gigantic sombrero-wearing straw donkey.

(BFW) TECHNICALS: WTI Crude Futures Fall as Much as 7.9%


TECHNICALS: WTI Crude Futures Fall as Much as 7.9%
2015-07-06 19:22:02.831 GMT


By William Maloney
(Bloomberg) -- Sink most since February.

* Down for 3rd day
* Break below both 100-DMA ($54.78) and 38.2% Fibonacci of
March low to May 6 high; chart
* 50% Fibonacci around $52.31
* 14-day RSI falls to 29; chart
* Breaks trading range; chart
* NOTE: Earlier, OIL FUTURES: Crude Drops Most in 5 Mos. on
Greece, China Concern
* NOTE: Earlier, Brent Crude Slumps Below $60 as Greece, China
Put Demand at Risk


For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

William Maloney is a Chartered Market Technician and Strategist
who writes for Bloomberg. The observations he makes are his own.

To contact the reporter on this story:
William Maloney in New York at +1-212-617-6437 or
wmaloney3@bloomberg.net
To contact the editor responsible for this story:
Larry DiTore at +1-212-617-1603 or
lditore@bloomberg.net

(BFW) Prosiebensat.1 Said in Talks to Combine W/ Axel Springer: DJ


BFW 07/06 18:43 *PROSIEBENSAT.1 SAID IN TALKS TO COMBINE W/ AXEL SPRINGER: DJ
Prosiebensat.1 Said in Talks to Combine W/ Axel Springer: DJ
2015-07-06 18:49:15.607 GMT


By Beth Mellor
(Bloomberg) -- Prosiebensat.1 is in talks to combine with
Axel Springer, Dow Jones reports, citing people familiar.

* Prosiebensat.1 would be senior partner in deal, people said
* Deal would value combined entity at >EU14b, DJ says
* Would face antitrust hurdles, DJ says, citing industry
experts
* NOTE: PSM GY reports 2Q July 30, SPR GY reports 2Q Aug. 4


For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
Beth Mellor in New York at +1-212-617-3078 or
bmellor@bloomberg.net
To contact the editors responsible for this story:
Arie Shapira at +1-212-617-1488 or
ashapira3@bloomberg.net
Beth Mellor

(BN) Teva Said Planning to Raise Mylan Bid to $86-$88/Share (1)


Teva Said Planning to Raise Mylan Bid to $86-$88/Share This Week
2015-07-06 16:17:39.188 GMT


By Ed Hammond and David Wainer
(Bloomberg) -- Teva Pharmaceutical Industries Ltd. is
preparing to raise its bid for rival drugmaker Mylan NV by as
much as $2 billion, to $43 billion, and may announce the
improved proposal as soon as this week, people with knowledge of
the matter said.
Teva may offer $86 to $88 a share for Mylan, said the
people, who asked not to be identified because the information
is private. That compares with the $82 a share Teva offered in
April, a price that valued the Canonsburg, Pennsylvania-based
company at about $40.1 billion. Mylan had a market value of
about $34.4 billion as of last week’s close.
Unlike its previous expression of interest, Teva plans to
make the next offer formal as it seeks to thwart the U.S.
drugmaker’s pursuit of Perrigo Co., the people said. Mylan is
planning to hold a shareholder meeting this summer to vote on
its Perrigo proposal, and an offer from Teva would pose an
alternative for proxy firms advising Mylan shareholders.
A new takeover proposal at the level Teva is contemplating
would mark the drug industry’s largest this year and signal an
intensifying battle for pharmaceutical assets that threatens to
become increasingly hostile.
Teva’s approach in April was based on the condition that
Mylan drop its bid for Perrigo. Mylan instead raised its offer
for the Dublin-based company to $32.7 billion, its third
proposal to be rebuffed.
Representatives for the companies declined to comment.

For Related News and Information:
Mylan Takes Fight to Teva’s Home Turf With Perrigo Meetings
Teva Buying Mylan Stock May Portend Showdown at Investor Meeting
Battle for Biggest Pharma Deal May Play Out in Dutch Court
Teva earnings graph: TEVA IT <Equity> FA ISBAR <GO>
Mylan product data: MYL US <Equity> FA PROD <GO>
Top health-industry news: TOP HEA <GO>

To contact the reporters on this story:
Ed Hammond in New York at +1-212-617-1963 or
ehammond12@bloomberg.net;
David Wainer in Tel Aviv at +972-3-542-7110 or
dwainer3@bloomberg.net
To contact the editors responsible for this story:
Jeffrey McCracken at +1-212-617-8517 or
jmccracken3@bloomberg.net
Elizabeth Wollman, Crayton Harrison

EXANE / GREEK REFERENDUM : "No" response



"No" opens up a wide range of market outcomes
Acknowledging what we do not know is as important as bragging over our insights. Under a "No" vote there is a wide range of potential outcomes and given the unprecedented nature of this event, the probabilities associated with each are unquantifiable. It is clear though that the European risk premium is not elevated, and offers little buffer against an adverse scenario.

"No" offers an asymmetric payoff profile
Clarity on the extent of the contagion, the efficacy of any ECB policy response and any spill-over damage into the real economy will take time to emerge. But we see heavy losses under an adverse 'No' scenario against only modest gains under a best case 'No' outcome. Benchmarking against previous periods of risk adjustment in European equities suggests a 15% peak to trough move in the Eurostoxx is easily plausible.

The "No" vote is most likely to lead to a Grexit
According to exit polls, the 'No' won with 61% in yesterday's referendum. In this situation, we believe Greece is very likely to leave the Eurozone. As the euro is a political project, we cannot completely rule out a turn in the current situation; however, we struggle to see the basis on which a deal can be found, given the current deadlock comes by and large down to a conflict of ideologies.

Politicians will want to keep Greece in the EU
The Grexit process itself would be a mix of European politicians not finding a compromise with Greece, Greek banks running out of funding and Greek authorities having to issue IOUs and a parallel currency. Ultimately, we believe the EU will be very willing to provide support through EU mechanisms, but without keeping Greece in the straightjacket of the Eurozone.

The euro's long-run taint
Expect periphery spreads to open sharply higher on Monday, with the ECB having to increase buying to contain the situation. In our view, the growth effect of a Grexit on the Eurozone should be manageable, with a confidence shock being the biggest risk. However, the situation reveals the shortcomings of the euro, which means euro assets should have a risk premium in the long-run.

(BFW) Brent Crude Drops Below $60 a Barrel First Time Since April 15

--> let's not forget than Iran deal should come very soon and push poil lower!!!
BFW 07/05 22:15 *BRENT CRUDE DROPS BELOW $60 A BARREL FIRST TIME SINCE APRIL 15
Brent Crude Drops Below $60 a Barrel First Time Since April 15
2015-07-05 22:23:04.705 GMT


By Ben Sharples
(Bloomberg) -- Futures decline as much as 97 cents, or
1.6%, to $59.35/bbl on the London-based ICE Futures Europe
exchange at 8:17 a.m. in Sydney.

* Prices fell 4.7% last wk
* WTI drops $2.29 from the June 2 close


For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the reporter on this story:
Ben Sharples in Melbourne at +61-3-9228-8732 or
bsharples@bloomberg.net

To contact the editor responsible for this story:
Alexander Kwiatkowski at +65-6212-1329 or
akwiatkowsk2@bloomberg.net

>>> Monsanto offers to rebrand enlarged company as part of USD 45bn takeover bid

Monsanto offers to rebrand enlarged company as part of USD 45bn takeover bid for Syngenta
Monsanto CEO Hugh Grant said the listed St Louis, Missouri-based agribusiness has offered to rebrand the enlarged group as part of its USD 45bn (CHF 42.31bn) takeover offer for listed Switzerland-based crop chemical producer Syngenta.

Grant, quoted in an interview with The Sunday Times, said he would be glad to rebrand the company to secure the deal.

Monsanto made an informal approach to Syngenta in April this year, which the Swiss group rejected, the item noted.

Grant visited Europe last week in an attempt to secure support from Syngenta shareholders and to force the company into negotiations, the item said. Grant said he had received an “encouraging” reception, according to the report.

Separately, Grant dismissed concerns about the risk of competition regulators derailing the deal as “overblown,” the article continued.

The newspaper’s Agenda column commented that Grant is likely to improve Monsanto’s CHF 449 (USD 477) per share offer for Syngenta.

Syngenta’s share price closed CHF 2.6 up at CHF 399.5 on Friday, 3 July, giving the company a market capitalisation of CHF 37.13bn.